FDA hosted its fourth summit on June 8, 2023, as an integral part of FDA’s overall efforts to protect the public, including youth, from harm associated with drugs that have abuse potential.
Similar Posts
Hans Kissle LLC Issues Allergy Alert on Undeclared Wheat (Allergen) in Hans Kissle Red Potato Bliss Salad
Haverhill, MA — Hans Kissle is voluntarily recalling 66 units of Hans Kissle Red Potato Bliss Salad due to undeclared allergen (wheat). People who have an allergy or severe sensitivity to wheat run the risk of serious or life-threatening allergic reaction if they consume these products.Meds for Vets. Sandy, UT. 483 issued 02/21/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 02/21/2025
Short Title (70 char) Meds for Vets. Sandy, UT. 483 issued 02/21/2025
FEI Number 3003829708
Firm Name Meds for Vets
Record Type 483
State UT
Establishment Type Producer of Sterile & Non-sterile Drug PM4Q(R2) The Common Technical Document for the Registration of Pharmaceuticals for Human Use: Quality
M4Q(R2) The Common Technical Document for the Registration of Pharmaceuticals for Human Use: QualityManual Resuscitator Recall: Ambu Inc. Removes SPUR II Resuscitators Due to Blocked Manometer Port
A blocked manometer port on the Ambu SPUR II resuscitator may delay ventilation or cause barotraumaOffice of Generic Drugs | Offices and Divisions
Generic Drugs Offices and DivisionsHintermann Series H3 Total Ankle Replacement Has a Higher-Than-Expected Risk of Device Failure: FDA Safety Communication
Learn more about recommendations for patients who are considering a Hintermann Series H3 TAR system or who have one; recommendations for health care providers.